Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Phillips, M. Tandon, G. Waterer, M. Dunkley, R. Clancy (Perth, Newcastle, NSW, Australia). HI-164, an oral vaccine to non-typable haemophilus influenzae, reduces antibiotic use, respiratory exacerbations and hospitalisations in patients with COPD. Eur Respir J 2007; 30: Suppl. 51, 1370

Member's Comments

No comment yet.

Related content which might interest you: Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD) Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Haemophilus influenzae in COPD patients with poorer lung function carry more antibiotic resistance Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Haemophilus influenza related respiratory infections and hospital re-admissions Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma Source: Eur Respir J, 56 (4) 2000194; 10.1183/13993003.00194-2020 Year: 2020 Microbiological efficacy of combined use of vaccines against S. pneumoniae, H. influenzae type B in patients with a COPD Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Pneumococcal vaccine in steroid-dependent COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae (NTHi) infection of COPD lung tissue Source: Eur Respir J 2006; 28: Suppl. 50, 841s Year: 2006 Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010 Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Impact of initial antibiotic choice on mortality from pneumococcal pneumonia Source: Eur Respir J 2006; 27: 1010-1019 Year: 2006 Antibiotics and new guidelines for the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175 Year: 2004 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Movement of Haemophilus influenzae types resistance isolated from sputum in patients with COPD in 2004 Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005 The impact of antibiotic resistance in the management of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131 Year: 2004 Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007 Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Associations between haemophilus influenzae and levels of sputum antimicrobial peptides in COPD Source: International Congress 2016 – Translational research in respiratory infections Year: 2016